Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Top Publications
Pittet, LF, Messina, NL, Gardiner, K, Freyne, B, Abruzzo, V, Morrison, C, Vuillermin, P, Allen, KJ, Ponsonby, A-L, Robins-Browne, R, et al.
Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials.
Dermatitis
33(3)
:
207 -214
2022
view publication
Pittet, LF, Fritschi, N, Tebruegge, M, Dutta, B, Donath, S, Messina, NL, Casalaz, D, Hanekom, WA, Britton, WJ, Robins-Browne, R, et al.
Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial..
American Journal of Respiratory and Critical Care Medicine
205(7)
:
830 -841
2022
view publication
Pittet, LF, Messina, NL, Gardiner, K, Freyne, B, Abruzzo, V, Francis, KL, Morrison, C, Zufferey, C, Vuillermin, P, Allen, KJ, et al.
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial.
Allergy
77(3)
:
956 -965
2022
view publication
Pittet, LF, Cox, L, Freyne, B, Germano, S, Bonnici, R, Gardiner, K, Donath, S, Collins, CL, Casalaz, D, Robins-Browne, R, et al.
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Vaccine
40(9)
:
1334 -1341
2022
view publication
Messina, NL, Germano, S, McElroy, R, Rudraraju, R, Bonnici, R, Pittet, LF, Neeland, MR, Nicholson, S, Subbarao, K, Curtis, N, et al.
Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19.
Clinical & Translational Immunology
11(4)
:
e1387
2022
view publication